Progressive myoclonic epilepsies

被引:8
作者
Conry, JA [1 ]
机构
[1] Childrens Natl Med Ctr, Washington, DC 20010 USA
关键词
D O I
10.1177/08830738020170011201
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The progressive myoclonic epilepsies area rare but extremely debilitating group or disorders that are difficult to generalized epilepsy. Efficacy and even harder to treat. They represent a heterogeneous subgroup of those with secondary generalized epilepsy. Efficacy of treatment is often Measured in terms of slowing a patient's inevitable decline. Reviewed here are the classification of progressive myoclonic epilepsies, features of myoclonic seizures, the five most prevalent progressive myoclonic epilepsy syndromes-Unverricht-Lundborg disease, myoclonus epilepsy with ragged red fibers (MERRF) mitochondrial disease, Lafora's disease, neuronal ceroid lipofuscinoses, and sialidoses-and current treatment options.
引用
收藏
页码:S80 / S84
页数:5
相关论文
共 18 条
[1]  
AICARDI J, 1996, EPILEPSY CHILDREN, P88
[2]  
[Anonymous], 1990, Ann Neurol, V28, P113
[3]  
BERKOVIC SF, 1997, PROGR MYOCLONIC EPIL, P2455
[4]  
Conry JA, 2001, ANN NEUROL, V50, pS101
[5]  
GANDY A, 2001, PROGR MYOCLONUS EPIL
[6]  
GANDY A, 2001, MYOCLONUS EPILEPSY
[7]   PROGRESSIVE MYOCLONUS EPILEPSY TREATED WITH ZONISAMIDE [J].
HENRY, TR ;
LEPPIK, IE ;
GUMNIT, RJ ;
JACOBS, M .
NEUROLOGY, 1988, 38 (06) :928-931
[8]   Zonisamide for progressive myoclonus epilepsy: long-term observations in seven patients [J].
Kyllerman, M ;
Ben-Menachem, E .
EPILEPSY RESEARCH, 1998, 29 (02) :109-114
[9]   Zonisamide [J].
Leppik, IE .
EPILEPSIA, 1999, 40 :S23-S29
[10]  
LEPPIK IE, 1999, TODAYS THERAPEUTIC T, V17, P181